Abstract
Shen–Zhi–Ling (SZL) is a Chinese medicine formulated from a Kai–Xin–San decoction that is commonly used to treat depression caused by dual deficiencies in the heart and spleen. However, the underlying mechanisms remain unclear. We investigated biological changes in depression patients (DPs) exhibiting antidepressant responses to SZL treatment using proteomic techniques. We performed label-free quantitative proteomic analysis and liquid chromatography–tandem mass spectrometry to discover and examine altered proteins involved in depression and antidepressant treatment. Serum samples were collected from DPs, DPs who underwent 8 weeks of SZL treatment and healthy controls (HCs). The proteins that differed among the three groups were further validated by Western blot analysis. By performing multivariate analyses, we identified 12 potential serum biomarkers that were differentially expressed among the HC, DP, and SZL groups. We then confirmed the significant changes in alpha-1-antitrypsin, von Willebrand factors, apolipoprotein C-III, and alpha-2-macroglobulin among the three groups by performing Western blot analysis, which supported the proteomic results. Profiling the proteomic changes in DPs treated with SZL could improve our understanding of the pathways involved in SZL responses, such as alterations in platelet activation, inflammatory regulation, and lipid metabolism. Future studies involving larger patient cohorts are necessary to draw more definitive conclusions.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amadio P, Colombo GI, Tarantino E, Gianellini S, Ieraci A, Brioschi M, Banfi C, Werba JP, Parolari A, Lee FS, Tremoli E, Barbieri SS (2017) BDNFVal66met polymorphism: a potential bridge between depression and thrombosis. Eur Heart J 38:1426–1435. https://doi.org/10.1093/eurheartj/ehv655
Armstrong PB (2001) The contribution of proteinase inhibitors to immune defense. Trends Immunol 22:47–52. https://doi.org/10.1016/S1471-4906(00)01803-2
Bahn S, Chan MK (2015) What can we learn about depression from gene expression in peripheral tissues? Biol Psychiatry 77:207–209. https://doi.org/10.1016/j.biopsych.2014.10.019
Bao ZX, Zhao GP, Sun W, Chen BJ (2011) Clinical curative effects of kaixin powder on depression with mild or moderate degree. Chin Arch Tradit Chin Med 28:987–988
Bot M, Chan MK, Jansen R, Lamers F, Vogelzangs N, Steiner J, Leweke FM, Rothermundt M, Cooper J, Bahn S, Penninx BW (2015) Serum proteomic profiling of major depressive disorder. Transl Psychiatry 5:e599. https://doi.org/10.1038/tp.2015.88
Butler L, Pilkington K (2013) Chinese herbal medicine and depression: the research evidence. Evid Based Complement Alternat Med 2013:739716. https://doi.org/10.1155/2013/739716
Canan A, Halıcioğlu SS, Gürel S (2012) Mean platelet volume and D-dimer in patients with suspected deep venous thrombosis. J Thromb Thrombolysis 34:283–287. https://doi.org/10.1007/s11239-012-0746-2
Dang H, Sun L, Liu X, Peng B, Wang Q, Jia W, Chen Y, Pan A, Xiao P (2009) Preventive action of Kai Xin San aqueous extract on depressive-like symptoms and cognition deficit induced by chronic mild stress. Exp Biol Med 234:785–793. https://doi.org/10.3181/0812-RM-354
Dimopoulos N, Piperi C, Salonicioti A, Mitsonis C, Liappas I, Lea RW, Kalofoutis A (2006) Elevation of plasma concentration of adhesion molecules in late-life depression. Int J Geriatr Psychiatry 21:965–971. https://doi.org/10.1002/gps.1592
Domenici E, Willé DR, Tozzi F, Prokopenko I, Miller S, McKeown A, Brittain C, Rujescu D, Giegling I, Turck CW, Holsboer F, Bullmore ET, Middleton L, Merlo-Pich E, Alexander RC, Muglia P (2010) Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. PLoS ONE 5:e9166. https://doi.org/10.1371/journal.pone.0009166
Dong XZ, Li ZL, Zheng XL, Mu LH, Zhang GQ, Liu P (2013) A representative prescription for emotional disease, Ding-Zhi-Xiao-Wan restores 5-HT system deficit through interfering the synthesis and transshipment in chronic mild stress-induced depressive rats. J Ethnopharmacol 150:1053–1061. https://doi.org/10.1016/j.jep.2013.10.018
Feige JJ, Negoescu A, Keramidas M, Souchelnitskiy S, Chambaz EM (1996) Alpha 2-macroglobulin: a binding protein for transforming growth factor-beta and various cytokines. Horm Res 45:227–232. https://doi.org/10.1159/000184793
Feng DD, Tang T, Lin XP, Yang ZY, Yang S, Xia ZA, Wang Y, Zheng P, Wang Y, Zhang CH (2016) Nine traditional Chinese herbal formulas for the treatment of depression: an ethnopharmacology, phytochemistry, and pharmacology review. Neuropsychiatr Dis Treat 12:2387–2402. https://doi.org/10.2147/NDT.S114560
Geiser F, Meier C, Wegener I, Imbierowicz K, Conrad R, Liedtke R, Oldenburg J, Harbrecht U (2008) Association between anxiety and factors of coagulation and fibrinolysis. Psychother Psychosom 77:377–383. https://doi.org/10.1159/000151518
Hsu MC, Creedy D, Moyle W, Venturato L, Tsay SL, Ouyang WC (2008) Use of complementary and alternative medicine among adult patients for depression in Taiwan. J Affect Disord 111:360–365. https://doi.org/10.1016/j.jad.2008.03.010
Hu Y, Liu P, Dai-Hong G, Rahman K, Wang D-X, Chen M-L, Xie T-T (2008) Behavioral and biochemical effects of Kaixin-San, a traditional Chinese medicinal empirical formula. Drug Dev Res 69:267–271. https://doi.org/10.1002/ddr.20252
Hu Y, Cao Y, Liu M, Liu P, Cui H, Dai-Hong G (2013) Behavioral and biochemical effects of a formulation of the traditional Chinese medicine, Kai-Xin-San, in fatigued rats. Exp Ther Med 6:973–976. https://doi.org/10.3892/etm.2013.1256
Hu Y, Zhou XJ, Liu P, Dong XZ, Mu LH, Chen YB, Liu MY, Yu BY (2014) Antidepressant and neuroprotective effect of the Chinese herb kaixinsan against lentiviral shRNA knockdown brain-derived neurotrophic factor-induced injury in vitro and in vivo. Neuropsychobiology 69:129–139. https://doi.org/10.1159/000358089
Huang TL (2005) Serum lipid profiles in major depression with clinical subtypes, suicide attempts and episodes. J Affect Disord 86:75–79. https://doi.org/10.1016/j.jad.2004.11.005
Huang TL, Wu SC, Chiang YS, Chen JF (2003) Correlation between serum lipid, lipoprotein concentrations and anxious state, depressive state or major depressive disorder. Psychiatry Res 118:147–153. https://doi.org/10.1016/S0165-1781(03)00071-4
Huang TL, Sung ML, Chen TY (2014) 2D-DIGE proteome analysis on the platelet proteins of patients with major depression. Proteome Sci 12:1. https://doi.org/10.1186/1477-5956-12-1
Ji Q, Zhu F, Liu X, Li Q, Su SB (2015) Recent advance in applications of proteomics technologies on traditional Chinese medicine research. Evid Based Complement Alternat Med 2015:983139. https://doi.org/10.1155/2015/983139
Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M (2004) The KEGG resource for deciphering the genome. Nucleic Acids Res 32:D277–D280. https://doi.org/10.1093/nar/gkh063
Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G (2005) Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 57:1068–1072. https://doi.org/10.1016/j.biopsych.2005.01.008
Kasper S, Fuger J, Möller HJ (1992) Comparative efficacy of antidepressants. Drugs 43:11–22. https://doi.org/10.2165/00003495-199200432-00004
Kessler RC, Soukup J, Davis RB, Foster DF, Wilkey SA, Van Rompay MI, Eisenberg DM (2001) The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiatry 158:289–294. https://doi.org/10.1176/appi.ajp.158.2.289
Khetarpal SA, Qamar A, Millar JS, Rader DJ (2016) Targeting apoC-III to reduce coronary disease risk. Curr Atheroscler Rep 18:54. https://doi.org/10.1007/s11883-016-0609-y
Kou MJ, Chen JX (2012) Integrated traditional and Western medicine for treatment of depression based on syndrome differentiation: a meta-analysis of randomized controlled trials based on the Hamilton depression scale. J Tradit Chin Med 32:1–5. https://doi.org/10.1016/S0254-6272(12)60023-5
LaMarre J, Wollenberg GK, Gonias SL, Hayes MA (1991) Cytokine binding and clearance properties of proteinase-activated alpha 2-macroglobulins. Lab Investig 65:3–14
Lang UE, Borgwardt S (2013) Molecular mechanisms of depression: perspectives on new treatment strategies. Cell Physiol Biochem 31:761–777. https://doi.org/10.1159/000350094
Lee BH, Kim YK (2009) Reduced platelet BDNF level in patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 33:849–853. https://doi.org/10.1016/j.pnpbp.2009.04.002
Lee J, Kim SH, Choi DS, Lee JS, Kim DK, Go G, Park SM, Kim SH, Shin JH, Chang CL, Gho YS (2015) Proteomic analysis of extracellular vesicles derived from Mycobacterium tuberculosis. Proteomics 15:3331–3337. https://doi.org/10.1002/pmic.201500037
Lee MY, Kim EY, Kim SH, Cho KC, Ha K, Kim KP, Ahn YM (2016) Discovery of serum protein biomarkers in drug-free patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 69:60–68. https://doi.org/10.1016/j.pnpbp.2016.04.009
Li S, Li X, Wang Y, Yang J, Chen Z, Shan S (2014) Global secretome characterization of A549 human alveolar epithelial carcinoma cells during Mycoplasma pneumoniae infection. BMC Microbiol 14:27. https://doi.org/10.1186/1471-2180-14-27
Liu J, Fang Y, Yang L, Qin X, Du G, Gao X (2015) A qualitative, and quantitative determination and pharmacokinetic study of four polyacetylenes from Radix Bupleuri by UPLC-PDA-MS. J Pharm Biomed Anal 111:257–265. https://doi.org/10.1016/j.jpba.2015.04.002
Lopez-Vilchez I, Diaz-Ricart M, Navarro V, Torramade S, Zamorano-Leon J, Lopez-Farre A, Galan AM, Gasto C, Escolar G (2016) Endothelial damage in major depression patients is modulated by SSRI treatment, as demonstrated by circulating biomarkers and an in vitro cell model. Transl Psychiatry 6:e886. https://doi.org/10.1038/tp.2016.156
Maes M (1993) A review on the acute phase response in major depression. Rev Neurosci 4:407–416. https://doi.org/10.1515/REVNEURO.1993.4.4.407
Maes M, Scharpe S, Bosmans E, Vandewoude M, Suy E, Uyttenbroeck W, Cooreman W, Vandervorst C, Raus J (1992) Disturbances in acute phase plasma proteins during melancholia: additional evidence for the presence of an inflammatory process during that illness. Prog Neuropsychopharmacol Biol Psychiatry 16:501–515. https://doi.org/10.1016/0278-5846(92)90056-K
Maes M, Nowak G, Caso JR, Leza JC, Song C, Kubera M, Klein H, Galecki P, Noto C, Glaab E, Balling R, Berk M (2016) Toward omics-based, systems biomedicine, and path and drug discovery methodologies for depression-inflammation research. Mol Neurobiol 53:2927–2935. https://doi.org/10.1007/s12035-015-9183-5
McCaffery JM, Duan QL, Frasure-Smith N, Barhdadi A, Lespérance F, Théroux P, Rouleau GA, Dubé MP (2009) Genetic predictors of depressive symptoms in cardiac patients. Am J Med Genet B Neuropsychiatr Genet 150B:381–388. https://doi.org/10.1002/ajmg.b.30824
Monteggia LM, Malenka RC, Deisseroth K (2014) Depression: the best way forward. Nature 515:200–201. https://doi.org/10.1038/515200a
Mu LH, Huang ZX, Liu P, Hu Y, Gao Y (2011) Acute and subchronic oral toxicity assessment of the herbal formula Kai-Xin-San. J Ethnopharmacol 138:351–357. https://doi.org/10.1016/j.jep.2011.08.033
Nemeroff CB, Musselman DL (2000) Are platelets the link between depression and ischemic heart disease? Am Heart J 140:57–62. https://doi.org/10.1067/mhj.2000.109978
Nguyen VA, Carey LM, Giummarra L, Faou P, Cooke I, Howells DW, Tse T, Macaulay SL, Ma H, Davis SM, Donnan GA, Crewther SG (2016) A pathway proteomic profile of ischemic stroke survivors reveals innate immune dysfunction in association with mild symptoms of depression—a pilot study. Front Neurol 7:85. https://doi.org/10.3389/fneur.2016.00085
Ormonde do Carmo MBO, Mendes-Ribeiro AC, Matsuura C, Pinto VL, Mury WV, Pinto NO, Moss MB, Ferraz MR, Brunini TMC (2015) Major depression induces oxidative stress and platelet hyperaggregability. J Psychiatr Res 61:19–24. https://doi.org/10.1016/j.jpsychires.2014.12.009
Papakostas GI, Shelton RC, Kinrys G, Henry ME, Bakow BR, Lipkin SH, Pi B, Thurmond L, Bilello JA (2013) Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study. Mol Psychiatry 18:332–339. https://doi.org/10.1038/mp.2011.166
Qin X, Li P, Han M, Liu Z, Liu J (2010) Systematic review of randomize controlled trials of Xiaoyao powder in treatment of depression. J Trad Chin Med 51:500–505
Qin F, Wu XA, Tang Y, Huang Q, Zhang ZJ, Yuan JH (2011) Meta-analysis of randomized controlled trials to assess the effectiveness and safety of Free and Easy Wanderer Plus, a polyherbal preparation for depressive disorders. J Psychiatr Res 45:1518–1524. https://doi.org/10.1016/j.jpsychires.2011.06.018
Qiong W, Yong-Liang Z, Ying-Hui L, Shan-Guang C, Jiang-Hui G, Yi-Xi C, Ning J, Xin-Min L (2016) The memory enhancement effect of Kai Xin San on cognitive deficit induced by simulated weightlessness in rats. J Ethnopharmacol 187:9–16. https://doi.org/10.1016/j.jep.2016.03.070
Qureshi NA, Al-Bedah AM (2013) Mood disorders and complementary and alternative medicine: a literature review. Neuropsychiatr Dis Treat 9:639–658. https://doi.org/10.2147/NDT.S43419
Roetker NS, Yonker JA, Lee C, Chang V, Basson JJ, Roan CL, Hauser TS, Hauser RM, Atwood CS (2012) Multigene interactions and the prediction of depression in the Wisconsin Longitudinal Study. BMJ Open 2:e000944. https://doi.org/10.1136/bmjopen-2012-000944
Sarris J, Panossian A, Schweitzer I, Stough C, Scholey A (2011) Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence. Eur Neuropsychopharmacol 21:841–860. https://doi.org/10.1016/j.euroneuro.2011.04.002
Scharinger C, Rabl U, Kasess CH, Meyer BM, Hofmaier T, Diers K, Bartova L, Pail G, Huf W, Uzelac Z, Hartinger B, Kalcher K, Perkmann T, Haslacher H, Meyer-Lindenberg A, Kasper S, Freissmuth M, Windischberger C, Willeit M, Lanzenberger R, Esterbauer H, Brocke B, Moser E, Sitte HH, Pezawas L (2014) Platelet serotonin transporter function predicts default-mode network activity. PLoS ONE 9:e92543. https://doi.org/10.1371/journal.pone.0092543
Schnyer RN, Flaws B (1998) Curing depression naturally with Chinese medicine. Blue Poppy Press, Boulder
Serretti A, Mandelli L, Lattuada E, Smeraldi E (2004) Depressive syndrome in major psychoses: a study on 1351 subjects. Psychiatry Res 127:85–99. https://doi.org/10.1016/j.psychres.2003.12.025
Simon GE, Savarino J, Operskalski B, Wang PS (2006) Suicide risk during antidepressant treatment. Am J Psychiatry 163:41–47. https://doi.org/10.1176/appi.ajp.163.1.41
Valkanova V, Ebmeier KP, Allan CL (2013) CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord 150:736–744. https://doi.org/10.1016/j.jad.2013.06.004
van Sloten TT, Schram MT, Adriaanse MC, Dekker JM, Nijpels G, Teerlink T, Scheffer PG, Pouwer F, Schalkwijk CG, Stehouwer CD, Henry RM (2014) Endothelial dysfunction is associated with a greater depressive symptom score in a general elderly population: the Hoorn Study. Psychol Med 44:1403–1416. https://doi.org/10.1017/S0033291713002043
von Känel R (2004) Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence? Acta Psychiatr Scand 110:163–177. https://doi.org/10.1111/j.1600-0447.2004.00308.x
Wang Y, Li M, Dai X, Fan G (1997) Internal Chinese Medicine. Shanghai Scientific and Technological Documentation Publishing House, Shanghai
Wang Y, Fan R, Huang X (2012) Meta-analysis of the clinical effectiveness of traditional Chinese medicine formula Chaihu-Shugan-San in depression. J Ethnopharmacol 141:571–577. https://doi.org/10.1016/j.jep.2011.08.079
World Health Organization, Western Pacific Region (2007) WHO international standard terminologies on traditional medicine in the western pacific region. World Health Organization, Manila
Wu R, Zhu D, Xia Y, Wang H, Tao W, Xue W, Xia B, Ren L, Zhou X, Li G, Chen G (2015) A role of Yueju in fast-onset antidepressant action on major depressive disorder and serum BDNF expression: a randomly double-blind, fluoxetine-adjunct, placebo-controlled, pilot clinical study. Neuropsychiatr Dis Treat 11:2013–2021. https://doi.org/10.2147/NDT.S86585
Xu HB, Zhang RF, Luo D, Zhou Y, Wang Y, Fang L, Li WJ, Mu J, Zhang L, Zhang Y, Xie P (2012) Comparative proteomic analysis of plasma from major depressive patients: identification of proteins associated with lipid metabolism and immunoregulation. Int J Neuropsychopharmacol 15:1413–1425. https://doi.org/10.1017/S1461145712000302
Yang Y, Chen J, Liu C, Fang L, Liu Z, Guo J, Cheng K, Zhou C, Zhan Y, Melgiri ND, Zhang L, Zhong J, Chen J, Rao C, Xie P (2016) The extrinsic coagulation pathway: a biomarker for suicidal behavior in major depressive disorder. Sci Rep 6:32882. https://doi.org/10.1038/srep32882
Yeung WF, Chung KF, Ng KY, Yu YM, Ziea ET, Ng BF (2014) A meta-analysis of the efficacy and safety of traditional Chinese medicine formula Ganmai Dazao decoction for depression. J Ethnopharmacol 153:309–317. https://doi.org/10.1016/j.jep.2014.02.046
Yeung WF, Chung KF, Ng KY, Yu YM, Zhang SP, Ng BF, Ziea ET (2015) Prescription of Chinese herbal medicine in pattern-based traditional Chinese medicine treatment for depression: a systematic review. Evid Based Complement Alternat Med 2015:160189. https://doi.org/10.1155/2015/160189
Zhan Y, Yang YT, You HM, Cao D, Liu CY, Zhou CJ, Wang ZY, Bai SJ, Mu J, Wu B, Zhan QL, Xie P (2014) Plasma-based proteomics reveals lipid metabolic and immunoregulatory dysregulation in post-stroke depression. Eur Psychiatry 29:307–315. https://doi.org/10.1016/j.eurpsy.2014.03.004
Zhang Y, Han M, Liu Z, Wang J, He Q, Liu J (2012) Chinese herbal formula Xiao Yao San for treatment of depression: a systematic review of randomized controlled trials. Evid Based Complement Alternat Med 2012:931636. https://doi.org/10.1155/2012/931636
Zhao H, Wan X, Chen JX (2009) A mini review of traditional Chinese medicine for the treatment of depression in China. Am J Chin Med 37:207–213. https://doi.org/10.1142/S0192415X09006771
Zheng P, Gao HC, Li Q, Shao WH, Zhang ML, Cheng K, Yang DY, Fan SH, Chen L, Fang L, Xie P (2012) Plasma metabonomics as a novel diagnostic approach for major depressive disorder. J Proteome Res 11:1741–1748. https://doi.org/10.1021/pr2010082
Zhou XJ, Liu M, Yan JJ, Cao Y, Liu P (2012) Antidepressant-like effect of the extracted of Kai Xin San, a traditional Chinese herbal prescription, is explained by modulation of the central monoaminergic neurotransmitter system in mouse. J Ethnopharmacol 139:422–428. https://doi.org/10.1016/j.jep.2011.11.027
Zhu KY, Xu SL, Choi RC, Yan AL, Dong TT, Tsim KW (2013) Kai-Xin-San, a Chinese herbal decoction containing ginseng radix et rhizoma, polygalae radix, acori tatarinowii rhizoma, and poria, stimulates the expression and secretion of neurotrophic factors in cultured astrocytes. Evid Based Complement Alternat Med 2013:731385. https://doi.org/10.1155/2013/731385
Acknowledgments
This study was supported by grants from the National Natural Science Foundation (Grant Nos. 81673877, 81373996, and 81173430).
Author information
Authors and Affiliations
Contributions
PL and CC conceived and designed the experiments. CC and XD performed the experiments and wrote the manuscript. CC and PL analyzed the data. YH, XZ, and LM contributed materials. All the authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethical Approval
All the experimental protocols involving human subjects were approved by the Ethics Committee of the Fourth Military Medical University (Xi’an, China).
Conflicts of interest
The authors declare no conflicts of interest.
Rights and permissions
About this article
Cite this article
Chen, C., Hu, Y., Dong, Xz. et al. Proteomic Analysis of the Antidepressant Effects of Shen–Zhi–Ling in Depressed Patients: Identification of Proteins Associated with Platelet Activation and Lipid Metabolism. Cell Mol Neurobiol 38, 1123–1135 (2018). https://doi.org/10.1007/s10571-018-0582-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-018-0582-9